SCHEMBL4766403

SCHEMBL4766403

CCOc1ccc(OC)cc1C1CC1C(=O)Nc1sc2c(c1C#N)CCNC2

nearest known ligand 0.43

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
TGFBR1 P36897 2/20 0.43
MGAM O43451 1/20 0.43
GAA P10253 1/20 0.43
SI P14410 1/20 0.43
MGAM2 Q2M2H8 1/20 0.43
ALDH1A1 P00352 9/20 0.43
POLB P06746 5/20 0.43
SMN1; SMN2 Q16637 3/20 0.43
L3MBTL1 Q9Y468 1/20 0.41
ITK Q08881 1/20 0.39
MAPT P10636 4/20 0.39
NPC1 O15118 4/20 0.39
RAB9A P51151 3/20 0.39
KMT2A Q03164 5/20 0.38
MEN1 O00255 4/20 0.38
KDM4E B2RXH2 2/20 0.38
HPGD P15428 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4771021 0.93 TGFBR1 (0.48) TGFBR1MGAMGAASIMGAM2
SCHEMBL4766163 0.91 RAB9A (0.41) ALDH1A1POLBSMN1; SMN2L3MBTL1MAPT
SCHEMBL2895460 0.88 NPC1 (0.41) ALDH1A1POLBSMN1; SMN2MAPTNPC1
SCHEMBL4768814 0.88 TGFBR1 (0.44) TGFBR1MGAMGAASIMGAM2
SCHEMBL4766539 0.87 TGFBR1 (0.42) TGFBR1MGAMGAASIMGAM2
SCHEMBL4776053 0.85 ALDH1A1 (0.44) TGFBR1MGAMGAASIMGAM2
SCHEMBL4775000 0.85 ALDH1A1 (0.45) MGAMGAASIMGAM2ALDH1A1
SCHEMBL2891422 0.82 ALDH1A1 (0.47) TGFBR1MGAMGAASIMGAM2
SCHEMBL2894804 0.82 NPC1 (0.49) TGFBR1MGAMGAASIMGAM2
SCHEMBL4771546 0.82 NPC1 (0.45) ALDH1A1POLBSMN1; SMN2MAPTNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1893618-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER Nycomed GmbH (DE) 2008-03-05 EP disclosed
WO-2006125815-A2 TETRAHYDROPYRIDOTHIOPHENES FOR USE IN THE TREATMENT OF CANCER NYCOMED GMBH (DE) 2006-11-30 WO disclosed